I suspect the anti-science bit has more to do with approving Keystone/DAPL than some hard line policy.

If Balaji Srinivasan is confirmed for the FDA, I'd expect gene therapies and stem cell treatments to become more commonplace. After all, Balaji's first startup dealt with genetic testing.

What is more concerning is that the US might face a brain drain in the coming years, due to the visa ban from so-called "terrorist" states (funny how Saudi Arabia is conspicuously absent from that list...)